To amend title 18, United States Code, to prohibit machinegun conversion devices and illegal modifications of semiautomatic firearms, and for other purposes.

Bill ID: 119/hr/2799
Last Updated: April 14, 2025

Sponsored by

Rep. Titus, Dina [D-NV-1]

ID: T000468

Follow the money

The bill

To amend title 18, United States Code, to prohibit machinegun conversion devices and illegal modifications of semiautomatic firearms, and for other purposes.

HR. 2799, 119th Congress — read as touching Defense Contractors.

The sponsor

Rep. Titus, Dina [D-NV-1]

Every bill has someone who introduced it. That name is where the paper trail starts.

The money

$78,850 raised

27 itemised contributions to this sponsor, pulled from FEC filings.

The alignment

55% match to Project 2025

This bill's text tracks the "Department of Homeland Security" section, p. 201-204 of the Mandate for Leadership.

Bill's Journey to Becoming a Law

Track this bill's progress through the legislative process

Latest Action

Invalid Date

Introduced

📍 Current Status

Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.

🏛️

Committee Review

🗳️

Floor Action

✅

Passed Senate

🏛️

House Review

🎉

Passed Congress

🖊️

Presidential Action

⚖️

Became Law

📚 How does a bill become a law?

1. Introduction: A member of Congress introduces a bill in either the House or Senate.

2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.

3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.

4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.

5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.

6. Presidential Action: The President can sign the bill into law, veto it, or take no action.

7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!

Bill Summary

Another brilliant example of legislative theater, courtesy of the esteemed members of Congress. Let's dissect this farce, shall we?

**Main Purpose & Objectives:** The "Closing the Bump Stock Loophole Act of 2025" is a masterclass in Orwellian doublespeak. The bill's primary objective is to prohibit machinegun conversion devices and modifications that increase the rate of fire of semiautomatic firearms. Or, in simpler terms, it's an attempt to ban bump stocks and other gadgets that make guns go " pew-pew-pew" faster.

**Key Provisions & Changes to Existing Law:** The bill amends Title 18 of the United States Code by adding a new definition for semiautomatic firearms and prohibiting the importation, sale, manufacture, transfer, receipt, or possession of devices that increase the rate of fire. It also requires registration of modified semiautomatic firearms within 120 days of enactment.

**Affected Parties & Stakeholders:** The usual suspects are involved in this legislative circus:

* Gun manufacturers and lobbyists, who will no doubt find creative ways to circumvent these new regulations. * Gun owners and enthusiasts, who will be forced to register their modified firearms or risk facing the wrath of the law. * Law enforcement agencies, which will have to deal with the bureaucratic nightmare of enforcing these new provisions.

**Potential Impact & Implications:** This bill is a classic case of treating the symptoms rather than the disease. By focusing on bump stocks and other gadgets, Congress is ignoring the root causes of gun violence in America. The real issue is not the devices themselves, but rather the lax regulations surrounding firearms sales, ownership, and use.

In reality, this bill will have little to no impact on reducing gun violence. It's a feel-good measure designed to appease the masses while allowing politicians to claim they're "doing something" about the problem. Meanwhile, the gun lobby will continue to pull the strings from behind the scenes, ensuring that meaningful reform remains elusive.

In medical terms, this bill is akin to treating a patient with a severe case of gangrene by applying a Band-Aid. It's a superficial solution that ignores the underlying rot and corruption that plagues our system.

And so, we're left with another example of legislative malpractice, where politicians prioritize grandstanding over genuine problem-solving. Bravo, Congress! You've managed to create a bill that is both ineffective and infuriating.

Generated using Llama 3.1 70B (Dr. Haus personality)

💰 Campaign Finance Network

Rep. Titus, Dina [D-NV-1]

Congress 119 • 2024 Election Cycle

Total Contributions
$78,850
24 donors
PACs
$0
Organizations
$12,850
Committees
$0
Individuals
$66,000

No PAC contributions found

1
SAN MANUEL BAND OF MISSION INDIANS
2 transactions
$5,800
2
LAS VEGAS PAIUTE TRIBE
1 transaction
$3,300
3
BARONA BAND OF MISSION INDIANS
1 transaction
$1,500
4
RENO-SPARKS INDIAN COLONY
1 transaction
$1,000
5
SANTA YNEZ BAND OF MISSION INDIANS
1 transaction
$1,000
6
NET2LINK, LLC
1 transaction
$250

No committee contributions found

1
ALSOP, JOSEPH W
2 transactions
$6,600
2
BROWN, JAY H.
2 transactions
$6,600
3
CHANG, RONIE
1 transaction
$3,300
4
PRITZKER, JAY
1 transaction
$3,300
5
SCHMIDT, ERIC
1 transaction
$3,300
6
CASHMAN, MARYKAYE
1 transaction
$3,300
7
GREENSPUN, MYRA S
1 transaction
$3,300
8
HAAS, GENE
1 transaction
$3,300
9
KELLNER, PETER
1 transaction
$3,300
10
SANDBERG, SHERYL
1 transaction
$3,300
11
SCOTT, MARIE RAY
1 transaction
$3,300
12
SUSSMAN, S. DONALD S
1 transaction
$3,300
13
TRONE, DAVID
1 transaction
$3,300
14
JURVETSON, KARLA
1 transaction
$3,300
15
SAMUELSON, MARTHA S
1 transaction
$3,300
16
SAMUELSON, PAUL
1 transaction
$3,300
17
BEKENSTEIN, ANITA
1 transaction
$3,300
18
BEKENSTEIN, JOSHUA
1 transaction
$3,300

Donor Network - Rep. Titus, Dina [D-NV-1]

PACs
Organizations
Individuals
Politicians

Hub layout: Politicians in center, donors arranged by type in rings around them.

Loading...

Showing 65 nodes and 27 connections (70 secondary connections hidden)

Total contributions: $78,850

Top Donors - Rep. Titus, Dina [D-NV-1]

Showing top 24 donors by contribution amount

6 Orgs18 Individuals

Industry Impact

Which industries are materially affected by specific provisions in this bill. 1 harmed.

  • −Defense Contractorsconfidence 0.90

    Section 2(a)(2) prohibits import, sale, manufacture, transfer, receipt, or possession of devices that increase rate of fire of semi-automatic firearms, affecting defense contractors that produce firearms and related components.

Project 2025 Policy Matches

This bill shows semantic similarity to the following sections of the Project 2025 policy document.AI-enhanced analysis provides detailed alignment ratings.

Department of Homeland Security

Weak
Vector: 57%
Pages: 201-204AI Enhanced

AI Analysis:

"HR 2799 focuses on gun‑control measures to curb mass shootings, whereas the Project 2025 DHS chapter emphasizes border security, immigration enforcement, and counterterrorism; the two share only a general concern for public safety and law‑enforcement roles."

Key themes:public safetylaw enforcementregulation

— 168 — Mandate for Leadership: The Conservative Promise ENDNOTES 1. H.R. 5005, Homeland Security Act of 2002, Public Law No. 107-296, 107th Congress, November 25, 2002, § 101(b)(1), https://www.congress.gov/107/plaws/publ296/PLAW-107publ296.pdf (accessed March 14, 2023). 2. See, for example, “Elon Musk Slams CISA Censorship Network as ‘Propaganda Platform,’” Kanekoa News, December 28, 2022, https://kanekoa.substack.com/p/elon-musk-slams-cisa-censorship-network (accessed March 14, 2023). 3. H.R. 2680, An Act to Amend the Immigration and Nationality Act, and for Other Purposes, Public Law No. 89-236, 89th Congress, October 3, 1965, https://www.govinfo.gov/content/pkg/STATUTE-79/pdf/STATUTE-79- Pg911.pdf (accessed March 14, 2023). 4. Added to the Immigration and Nationality Act by the Illegal Immigration Reform and Immigrant Responsibility Act of 1996. See H.R. 3610, Omnibus Consolidated Appropriations Act, 1997, Public Law No. 104-208, 104th Congress, September 30, 1996, Division C, https://www.congress.gov/104/plaws/publ208/ PLAW-104publ208.pdf (accessed March 14, 2023). 5. 8 U.S. Code, https://www.law.cornell.edu/uscode/text/8 (accessed March 14, 2023). 6. 18 U.S. Code, https://www.law.cornell.edu/uscode/text/18 (accessed March 14, 2023). 7. 5 U.S. Code §§ 551–559, https://www.law.cornell.edu/uscode/text/5/part-I/chapter-5/subchapter-II (accessed March 14, 2023). 8. Table, “United States Citizenship and Immigration Services Budget Comparison and Adjustments Appropriation and PPA Summary,” in U.S. Department of Homeland Security, United States Citizenship and Immigration Services, Department of Homeland Security, United States Citizenship and Immigration Services, Budget Overview, Fiscal Year 2023 Congressional Justification, p. CIS-4, https://www.uscis.gov/ sites/default/files/document/reports/U.S._Citizenship_and_Immigration_Services%E2%80%99_Budget_ Overview_Document_for%20Fiscal_Year_2023.pdf#:~:text=The%20FY%202023%20Budget%20includes%20 %24913.6M%2C%204%2C001%20positions%3B,of%20%24444.1M%20above%20the%20FY%202022%20 President%E2%80%99s%20Budget (accessed March 14, 2023), and Table, “United States Citizenship and Immigration Services Comparison of Budget Authority and Request,” in ibid., p. CIS-5. 9. H.R. 7311, William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008, Public Law No. 110-457, 110th Congress, December 23, 2008, § 235, https://www.congress.gov/110/plaws/publ457/PLAW- 110publ457.pdf (accessed March 15, 2023). 10. Matter of A-B-, Respondent, 27 I&N Dec. 316 (A.G. 2018), https://www.justice.gov/eoir/page/file/1070866/ download (accessed January 18, 2023). 11. Arizona v. United States, 567 U.S. 387 (2012), https://supreme.justia.com/cases/federal/us/567/387/ (accessed January 18, 2023). 12. Robert T. Stafford Disaster Relief and Emergency Assistance Act [Public Law 93–288; Approved May 22, 1974] [As Amended Through P.L. 117–328, Enacted December 29, 2022], https://www.govinfo.gov/content/pkg/ COMPS-2977/pdf/COMPS-2977.pdf (accessed March 15, 2023). 13. U.S. Department of Homeland Security, Federal Emergency Management Agency, Department of Homeland Security, Federal Emergency Management Agency, Budget Overview, Fiscal Year 2023 Congressional Justification, p. FEMA-24, https://www.dhs.gov/sites/default/files/2022-03/Federal%20Emergency%20 Management%20Agency_Remediated.pdf (accessed March 15, 2023). 14. Report, United States Secret Service: An Agency in Crisis, Committee on Oversight and Government Reform, U.S. House of Representatives, 114th Congress, December 9, 2015, https://republicans-oversight.house.gov/ wp-content/uploads/2015/12/Oversight-USSS-Report.pdf (accessed January 18, 2023). 15. 5 U.S. Code § 7103, https://www.law.cornell.edu/uscode/text/5/7103 (accessed March 15, 2023). 16. S. 3418, Privacy Act of 1974, Public Law No. 93-579, 93rd Congress, December 31, 1974, https://www.govinfo. gov/content/pkg/STATUTE-88/pdf/STATUTE-88-Pg1896.pdf (accessed March 15, 2023). 17. H.R. 1428, Judicial Redress Act of 2015, Public Law No. 114-126, 114th Congress, February 24, 2016, https://www. congress.gov/114/plaws/publ126/PLAW-114publ126.pdf (accessed March 15, 2023). 18. H.R. 1158, Consolidated Appropriations Act, 2020, Public Law No. 116-93, 116th Congress, December 20, 2019, https://www.congress.gov/bill/116th-congress/house-bill/1158 (accessed January 18, 2023).

Department of Health and Human Services

Minimal
Vector: 58%
Pages: 488-490AI Enhanced

AI Analysis:

"The bill concerns firearm regulation and bump stock prohibition, whereas the Project 2025 HHS section addresses abortion data reporting, FDA drug competition, laboratory-developed tests, and drug shortages, with no thematic overlap."

— 456 — Mandate for Leadership: The Conservative Promise abortion providers and whether better prenatal physical, mental, and social care improves infant outcomes and decreases abortion rates, especially among those who are most vulnerable. The Ensuring Accurate and Complete Abortion Data Reporting Act of 20239 would amend title XIX of the Social Security Act and Public Health Service Act to improve the CDC’s abortion reporting mechanisms by requiring states, as a condition of federal Medicaid payments for family planning services, to report streamlined variables in a timely manner. The CDC should immediately end its collection of data on gender identity, which legitimizes the unscientific notion that men can become women (and vice versa) and encourages the phenomenon of ever-multiplying subjective identities. FOOD AND DRUG ADMINISTRATION (FDA) The FDA’s mission includes ensuring the safety and efficacy of drugs, biological products, and medical devices. Federal Laws That Shield Big Pharma from Competition. Because generics generally cost far less than brand-name drugs, consumers begin to save money as soon as a generic product comes on the market. The vast majority are very afford- able with 93 percent of generic products costing $20 or less. Savings would be even higher under proposals that prevent brand-name man- ufacturers from slowing down or impeding the entrance of generic products into the marketplace. Specifically, the FDA should prohibit pharmaceutical companies from purposely sitting on their legally available right to be the first to sell generic versions of their drugs. Additionally, Congress should create legal remedies for generic companies to obtain samples of brand-name products for their generic development efforts and should prohibit meritless “citizen petitions” submitted by manufacturers to delay approval of a generic competitor.10 Approval Process for Laboratory-Developed or Modified Medical Tests. Learning from the failed early COVID-19 testing experience, Congress and the FDA should focus on reforming laws and regulations governing medical tests, especially with respect to laboratory-developed tests. Commercial tests are developed with the intention of being widely marketed, distributed, and used, while laboratory-developed tests are created with the intention of being used solely within one laboratory. A test developed by a lab in accordance with the protocols developed by another lab (non-commercial sharing) currently constitutes a “new” laboratory-developed test because the lab in which it will be used is different from the initial developing lab. To encourage interlab- oratory collaboration and discourage duplicative test creation (and associated regulatory and logistical burdens), the FDA should introduce mechanisms through which laboratory-developed tests can easily be shared with other laboratories with- out the current regulatory burdens.11 — 457 — Department of Health and Human Services The “laboratory-developed tests” category currently encompasses a range of possible tests, many of which would be characterized more appropriately as “lab- oratory-modified tests” because they are not truly novel tests but rather modified versions of existing tests. To avoid stifling innovation and access to medical care, the applicable statutes and regulations should be revised to facilitate greater access to such modified tests.12 Finally, the FDA has long held that it has regulatory authority over such tests, while others have argued that they should be considered clinical services regulated by the Centers for Medicare and Medicaid Services (CMS). The FDA currently has regulatory authority over in vitro diagnostics, and under the Clinical Lab- oratory Improvement Amendments (CLIA),13 the CMS ensures that labs meet analytical validity standards for test methods. Congress, the FDA, and the CMS need to clarify and disentangle overlapping authorities over tests to eliminate regulatory confusion.14 Drug Shortages. The very thin profit margins and the regulatory burdens associated with generic drug manufacturing discourage inventory and capacity investments by manufacturers and contribute to drug shortages. HHS and the FDA should encourage more dependable generic drug manufacturing. The FDA should expand its current pass/fail approach to drug facility inspec- tions into a graded system that recognizes manufacturers that exceed minimum standards by investing in improving production reliability. The FDA should also add facility codes to drug packaging and construct a searchable database that cross-references product codes and facility codes. That would enable wholesalers and pharmacy benefit managers to identify and preference drugs manufactured at more reliable facilities, thus encouraging generic drug manufacturers to compete on reliability as well as on price. For its part, HHS should exempt multi-source generic drugs from requirements to pay rebates to Medicaid and other federally funded health programs, as those provisions penalize new investments in expanding manufacturing capacity when supply is unable to meet demand.15 Additionally, FDA and NIH should promote efficacy trials of new applications for generic drugs, which might include NIH fund- ing such trials or conducting its own. Abortion Pills. Abortion pills pose the single greatest threat to unborn chil- dren in a post-Roe world. The rate of chemical abortion in the U.S. has increased by more than 150 percent in the past decade; more than half of annual abortions in the U.S. are chemical rather than surgical. The abortion pill regimen is typically a two-part process. The first pill, mifepris- tone, causes the death of the unborn child by cutting off the hormone progesterone, which is required to sustain a pregnancy. The second pill, misoprostol, causes con- tractions to induce a delivery of the dead child and uterine contents, usually into a toilet at home. The abortion-pill regimen is currently approved for up to 70 days

Environmental Protection Agency

Minimal
Vector: 58%
Pages: 458-460AI Enhanced

AI Analysis:

"The bill addresses firearm regulation and bump stocks, while the Project 2025 excerpt concerns EPA regulatory reforms, greenhouse gas reporting, and HFC regulation; there is no substantive thematic overlap."

— 425 — Environmental Protection Agency are statutorily required, and remove any regulatory differences between attainment and maintenance that are not explicitly required by law. l Streamline the process for state and local governments to demonstrate that their federally funded highway projects will not interfere with NAAQS attainment. l Adopt policies to prevent abuse of EPA’s CAA “error correction” authority.20 EPA historically has used this to coerce states into adopting its favored policies on pain of imposition of a Federal Implementation Plan (FIP). l Limit EPA’s reliance on CAA § 30121 general rulemaking authority to ensure that it is not abused to issue regulations for which EPA lacks substantive authority elsewhere in the statute. l If possible, return the standard-setting role to Congress. Climate Change l Remove the Greenhouse Gas Reporting Program (GHGRP) for any source category that is not currently being regulated. The overall reporting program imposes significant burdens on small businesses and companies that are not being regulated. This is either a pointless burden or a sword-of- Damocles threat of future regulation, neither of which is appropriate. l Establish a system, with an appropriate deadline, to update the 2009 endangerment finding. l Establish a significant emissions rate (SER) for greenhouse gasses (GHGs). Regulating Hydrofluorocarbons (HFCs) Under the American Innovation and Manufacturing (AIM) Act22 l Repeal Biden Administration implementing regulations for the AIM Act that are unnecessarily stringent and costly. l Refrain from granting petitions from opportunistic manufacturers to add new restrictions that further skew the market toward costlier refrigerants and equipment.

Showing 3 of 5 policy matches

About These Correlations

Policy matches are calculated using a hybrid approach: initial candidates are found using semantic similarity between bill summaries and Project 2025 policy text, then an AI model (Llama 3.1 70B) provides detailed alignment ratings and analysis. Ratings range from 1 (minimal alignment) to 5 (very strong alignment). This analysis does not imply direct causation or intent.

Full Policy Text

Related Bills